Fundraising FoxPressure Biosciences
South Easton, US · Massachusetts corporation
Find your way into Pressure Biosciences
Sign up to see every warm intro you have to Pressure Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pressure Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JL
Joseph L. Damasio, Jr.Executive
AL
Alexander LazarevExecutive
NP
Nathan P. LawrenceExecutiveNathan P. Lawrence is Executive Officer at Pressure Biosciences, which develops sample preparation systems. He has held executive-level positions directing research and development, operations, marketing, and sales.
Board
GG
Gregory G. FreitagBoard director
AI
Alan I. GoldbergBoard director
JD
J. Donald PayneBoard director
JN
Jeffrey N. PetersonBoard director
RW
R. Wayne FritzscheBoard director
CA
Calvin A. SaravisBoard director
AD
Alan D. RosensonBoard director
Reported raises · per SEC filings
Form D private placements$23.3M disclosed across 3 rounds · 2012–2018
▶$17.5MraisedMar 2019 · 43 investors · BiotechnologyRule 506(b)
▶$17.5MraisedMar 2019 · 43 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey N. PetersonDirector
- Kevin A. PollackDirector
- Richard P. ThomleyExecutive Officer
- Michael S. UrdeaDirector
- Richard T. SchumacherExecutive Officer, Director
- Vito J. MangiardiDirector
- Amount sold
- $17.5M
- Sales commissions
- $416.3K
- First sale
- May 2018
- Incorporated
- Corporation, Massachusetts
- Federal exemptions
- 06b
▶$5MraisedJan 2016 · 22 investors · BiotechnologyRule 506(b)
▶$5MraisedJan 2016 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard SchumacherExecutive Officer, Director
- Offering amount
- $6.3M
- Amount sold
- $5M
- Minimum investment
- $10K
- Sales commissions
- $460K
- Placement agents
- Garden State Securities, Inc.
- First sale
- Jul 2015
- Incorporated
- Corporation, Massachusetts
- Federal exemptions
- 06b
▶$800KraisedFeb 2012 · 7 investors · BiotechnologyRule 506(b)
▶$800KraisedFeb 2012 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph L. Damasio, Jr.Executive Officer
- Gregory G. FreitagDirector
- Alexander LazarevExecutive Officer
- Alan I. GoldbergDirector
- Edmund Y. TingExecutive Officer
- J. Donald PayneDirector
- Richard T. SchumacherExecutive Officer, Director
- Nathan P. LawrenceExecutive Officer
- Jeffrey N. PetersonDirector
- R. Wayne FritzscheDirector
- Calvin A. SaravisDirector
- Alan D. RosensonDirector
- Offering amount
- $800K
- Amount sold
- $800K
- Sales commissions
- $35K
- Placement agents
- Ladenburg Thalmann & Co. Inc.
- First sale
- Feb 2012
- Incorporated
- Corporation, Massachusetts
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Pressure Biosciences?
- Pressure Biosciences was founded by Richard Schumacher.
- How much funding has Pressure Biosciences raised?
- Pressure Biosciences has disclosed $23.3M raised across 3 rounds.
- Where is Pressure Biosciences headquartered?
- Pressure Biosciences is headquartered in South Easton, US.